Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Colin Hislop
Observed names:
C Hislop,
C. Hislop,
COLIN HISLOP,
Colin M. Hislop
Institutions:
Stanford Medicine,
Eiger Biopharmaceuticals (United States),
Stanford University
Observed institutions:
Associação de Assistência à Criança Deficiente,
Stanford Medicine,
Eiger Biopharmaceuticals (United States),
Anthera Pharmaceuticals (United States),
Stanford University
OpenAlex ID:
A5006919099
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
2021
·
Jordan J Feld
, Christopher Kandel
, et al.
·
The Lancet Respiratory Medicine
·
248
PDF
Early Treatment with Pegylated Interferon Lambda for Covid-19
2023
·
Gilmar Reis
, Eduardo A.S. Moreira Silva
, et al.
·
New England Journal of Medicine
·
190
PDF
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
2014
·
R A Furie
, G Leon
, et al.
·
Annals of the Rheumatic Diseases
·
179
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
2021
·
Prasanna Jagannathan
, Jason R. Andrews
, et al.
·
Nature Communications
·
138
PDF
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial
2009
·
Robert S Rosenson
, Colin Hislop
, et al.
·
The Lancet
·
117
Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients
2010
·
Robert S. Rosenson
, Colin Hislop
, et al.
·
Journal of the American College of Cardiology
·
97
Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE− / − Mice
2009
·
Heather Fraser
, Colin Hislop
, et al.
·
Journal of Cardiovascular Pharmacology
·
90
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease
2010
·
Robert S. Rosenson
, Michael Elliott
, et al.
·
European Heart Journal
·
69
Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial
2011
·
Stephen J. Nicholls
, Matthew A. Cavender
, et al.
·
Cardiovascular Drugs and Therapy
·
46
Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
2023
·
Ohad Etzion
, Saeed Sadiq Hamid
, et al.
·
Journal of Hepatology
·
40
Varespladib methyl in cardiovascular disease
2010
·
Robert S Rosenson
, Heather Fraser
, et al.
·
Expert Opinion on Investigational Drugs
·
22
Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser
2016
·
Morton A. Scheinberg
, Colin M. Hislop
, et al.
·
Expert Opinion on Biological Therapy
·
18
Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome
2011
·
Robert S. Rosenson
, Heather Fraser
, et al.
·
Cardiovascular Drugs and Therapy
·
18
AB0412 Exploratory Results from The Bliss and Illuminate Trials Support The Design of The CHABLIS-SC1 Trial, A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Efficacy and Safety of Blisibimod Administration in Subjects with Systemic Lupus Erythematosus
2016
·
J.T. Merrill
, V. Strand
, et al.
·
Annals of the Rheumatic Diseases
·
4
Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy
2013
·
A. P. F. Golmia
, R. Martin
, et al.
·
Rheumatology
·
4
OP0116 Effects of Blisibimod, a Subcutaneous Inhibitor of B Cell Activating Factor, in Patients with SLE
2013
·
R. Furie
, M. Scheinberg
, et al.
·
Annals of the Rheumatic Diseases
·
4
Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients
2010
·
Robert S. Rosenson
, Colin Hislop
·
Journal of the American College of Cardiology
·
4
PDF
Abstract 1928: Effects of a Selective Inhibitor of Secretory Phospholipase A2 on Low Density and Very Low Density Lipoprotein Subclasses in Stable Coronary Heart Disease Patients
2008
·
Robert S. Rosenson
, Colin Hislop
, et al.
·
Circulation
·
3
THU0387 Effects of Blisibimod, An Inhibitor of B Cell Activating Factor, On Patient Reported Outcomes and Disease Activity in Patients with Systemic Lupus Erythematosus
2015
·
M. Petri
, R.S. Martin
, et al.
·
Annals of the Rheumatic Diseases
·
2
OP0129 Effects of Blisibimod, an Inhibitor of B-Cell Activating Factor, on Markers of Renal Disease in Patients with SLE
2013
·
R. Furie
, M. Scheinberg
, et al.
·
Annals of the Rheumatic Diseases
·
2
FRI0388 Effects of Blisibimod on Serum Immunoglobulins and Infection Risk in Patients with Systemic Lupus Erythematosus from the Placebo-Controlled PEARL-SC and Open-Label Extension Studies
2014
·
F.A. Richard
, M.A. Scheinberg
, et al.
·
Annals of the Rheumatic Diseases
·
1
OC2.2 - ECE_3929 - JUV-161 restores glucose homeostasis and skeletal muscle function in Type 2 diabetic mouse model
2026
·
Vengadeshprabhu Karuppagounder
, Ritwik Datta
, et al.
·
European Journal of Endocrinology
PDF
P172 - ECE_3990 - JUV-161 reverses skeletal muscle myopathy and functional decline in a translational model of myotonic dystrophy type 1
2026
·
Ashil Koranne
, Hee Ju Kim
, et al.
·
European Journal of Endocrinology
EP739 - ECE_3957 - A novel secreted protein, JUV-161, reverses structural and functional muscle decline in Sarcopenia
2026
·
Ashil Koranne
, Hee Ju Kim
, et al.
·
European Journal of Endocrinology
PDF
3052-LB: JUV161 Improves Glycemic Control and Restores Skeletal Muscle Function as Monotherapy and Combination Therapy in a Type 2 Diabetes Mouse Model
2026
·
VENGADESHPRABHU KARUPPAGOUNDER
, RITWIK DATTA
, et al.
·
Diabetes
Show more works
View as search
Works count:
32
Citation count:
1,296
H-index:
13
I10-index:
13
Year
Topic
Type